메뉴 건너뛰기




Volumn 22, Issue 2, 2003, Pages 193-194

Novel therapeutic perspectives in pulmonary arterial hypertension

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; PROSTACYCLIN DERIVATIVE; SILDENAFIL; SITAXSENTAN; UNIPROST;

EID: 0042527637     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00054103     Document Type: Editorial
Times cited : (14)

References (23)
  • 1
    • 0031031440 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336: 111-117.
    • (1997) N. Engl. J. Med. , vol.336 , pp. 111-117
    • Rubin, L.J.1
  • 2
    • 0024422399 scopus 로고
    • Primary pulmonary hypertension. Vascular structure, morphometry and responsiveness to vasodilators agents
    • Palevsky HI, Schloo BL, Pietra GG, et al. Primary pulmonary hypertension. Vascular structure, morphometry and responsiveness to vasodilators agents. Circulation 1989; 80: 1207-1221.
    • (1989) Circulation , vol.80 , pp. 1207-1221
    • Palevsky, H.I.1    Schloo, B.L.2    Pietra, G.G.3
  • 3
    • 0031869664 scopus 로고    scopus 로고
    • Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension
    • Sitbon O, Humbert M, Jagot JL, et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 1998; 12: 265-270.
    • (1998) Eur. Respir. J. , vol.12 , pp. 265-270
    • Sitbon, O.1    Humbert, M.2    Jagot, J.L.3
  • 4
    • 0037111455 scopus 로고    scopus 로고
    • Therapy of pulmonary hypertension: The evolution from vasodilators to antiproliferative agents
    • Rubin LJ. Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents. Am J Respir Crit Care Med 2002; 166: 1309-1310.
    • (2002) Am. J. Respir. Crit. Care Med. , vol.166 , pp. 1309-1310
    • Rubin, L.J.1
  • 5
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    • Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-302.
    • (1996) N. Engl. J. Med. , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3
  • 6
    • 0037149718 scopus 로고    scopus 로고
    • Bosentan therapy for pulmonary arterial hypertension
    • Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
    • (2002) N. Engl. J. Med. , vol.346 , pp. 896-903
    • Rubin, L.J.1    Badesch, D.B.2    Barst, R.J.3
  • 7
    • 0037151645 scopus 로고    scopus 로고
    • Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival
    • Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788.
    • (2002) J. Am. Coll. Cardiol. , vol.40 , pp. 780-788
    • Sitbon, O.1    Humbert, M.2    Nunes, H.3
  • 8
    • 0037126044 scopus 로고    scopus 로고
    • Survival in primary pulmonary hypertension: The impact of epoprostenol therapy
    • McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106: 1477-1482.
    • (2002) Circulation , vol.106 , pp. 1477-1482
    • McLaughlin, V.V.1    Shillington, A.2    Rich, S.3
  • 9
    • 0036800014 scopus 로고    scopus 로고
    • The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
    • Galiè N, Manes A, Branzi A. The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J 2002; 20: 1037-1049.
    • (2002) Eur. Respir. J. , vol.20 , pp. 1037-1049
    • Galiè, N.1    Manes, A.2    Branzi, A.3
  • 10
    • 0037086133 scopus 로고    scopus 로고
    • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind randomized controlled trial
    • Simonneau G, Barst RJ, Galiè N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind randomized controlled trial. Am J Respir Crit Care Med 2002; 165: 800-804.
    • (2002) Am. J. Respir. Crit. Care Med. , vol.165 , pp. 800-804
    • Simonneau, G.1    Barst, R.J.2    Galiè, N.3
  • 11
    • 0036569119 scopus 로고    scopus 로고
    • Effects of beraprost sodium, an oral prostaeyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind placebo-controlled trial
    • Galiè N, Humbert M, Vachiéry JL, et al Effects of beraprost sodium, an oral prostaeyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind placebo-controlled trial. J Am Coll Cardiol 2002; 39: 1496-1502.
    • (2002) J. Am. Coll. Cardiol. , vol.39 , pp. 1496-1502
    • Galiè, N.1    Humbert, M.2    Vachiéry, J.L.3
  • 12
    • 0036682273 scopus 로고    scopus 로고
    • Inhaled iloprost in severe pulmonary hypertension
    • Olschewski H, Simonneau G, Galiè N, et al. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med 2002; 347: 322-327.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 322-327
    • Olschewski, H.1    Simonneau, G.2    Galiè, N.3
  • 13
    • 0036283401 scopus 로고    scopus 로고
    • Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension
    • Barst RJ, Rich SA, Horn EM, McLaughlin VV, McFarlin J. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension. Chest 2002; 121: 1860-1868.
    • (2002) Chest , vol.121 , pp. 1860-1868
    • Barst, R.J.1    Rich, S.A.2    Horn, E.M.3    McLaughlin, V.V.4    McFarlin, J.5
  • 15
    • 0037484589 scopus 로고    scopus 로고
    • Effect of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: A one year follow-up study
    • (in press)
    • Sitbon O, Badesch DB, Cjannick RN, et al. Effect of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a one year follow-up study. Chest 2003; (in press).
    • (2003) Chest
    • Sitbon, O.1    Badesch, D.B.2    Cjannick, R.N.3
  • 16
    • 0041742185 scopus 로고    scopus 로고
    • Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids
    • Hoeper MM, Taha N, Bekjarova A, Gatzke R, Spickerkoetter E. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Eur Respir J 2003; 22: 330-334.
    • (2003) Eur. Respir. J. , vol.22 , pp. 330-334
    • Hoeper, M.M.1    Taha, N.2    Bekjarova, A.3    Gatzke, R.4    Spickerkoetter, E.5
  • 17
    • 0037868048 scopus 로고    scopus 로고
    • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
    • (in press)
    • Ghofrani A, Rose F, Schermuly RT, et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003; (in press).
    • (2003) J. Am. Coll. Cardiol.
    • Ghofrani, A.1    Rose, F.2    Schermuly, R.T.3
  • 18
    • 0032145492 scopus 로고    scopus 로고
    • Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: A therapeutic alternative for patients nonresponsive to vasodilator treatment
    • Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998; 32: 297-304.
    • (1998) J. Am. Coll. Cardiol. , vol.32 , pp. 297-304
    • Sandoval, J.1    Gaspar, J.2    Pulido, T.3
  • 19
  • 21
    • 0037006966 scopus 로고    scopus 로고
    • Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension
    • Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136: 515-522.
    • (2002) Ann. Intern. Med. , vol.136 , pp. 515-522
    • Ghofrani, H.A.1    Wiedemann, R.2    Rose, F.3
  • 22
    • 0036852964 scopus 로고    scopus 로고
    • Amplification of the pulmonary vasodilatory response to inhaled iloprost by subtreshold phosphodiesterases types 3 and 4 inhibition in severe pulmonary hypertension
    • Ghofrani HA, Rose F, Schermuly RT, et al. Amplification of the pulmonary vasodilatory response to inhaled iloprost by subtreshold phosphodiesterases types 3 and 4 inhibition in severe pulmonary hypertension. Crit Care Med 2002; 30: 2489-2492.
    • (2002) Crit. Care Med. , vol.30 , pp. 2489-2492
    • Ghofrani, H.A.1    Rose, F.2    Schermuly, R.T.3
  • 23
    • 0041782976 scopus 로고    scopus 로고
    • Safety and efficacy of bosentan in combination with epoprostenol in patients with severe pulmonary arterial hypertension
    • (abstract)
    • Humbert M, Barst RJ, Robbins I, et al Safety and efficacy of bosentan in combination with epoprostenol in patients with severe pulmonary arterial hypertension (abstract). Am J Respir Crit Care Med 2003; 167: A441.
    • (2003) Am. J. Respir. Crit. Care Med. , vol.167
    • Humbert, M.1    Barst, R.J.2    Robbins, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.